The Patent Finder
CT

Carmot Therapeutics Inc.

First filing 2020
OverviewNotableFeesChangesFamiliesPatent listSources & methods

Three patents currently held, every record listed here

1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next term ends in Mar 2039. from the record

Of the 1 now held by other companies, 1 name Amgen Inc. as their current owner. Each row says so.

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Mar 2039
Next term end
3
Patent families

When these terms end

Each bar runs from grant to computed term end. 2022 to 2042.
US 11,535,660 Modulators of G-Protein Coupled Receptors Mar 22, 2039
US 11,572,374 N-CYANO-7-Azanorbornane Derivatives and Uses Thereof Aug 16, 2039
US 12,459,929 GPCR Receptor Agonists, Pharmaceutical Compositions Comprising the Same, and Methods for Their Use Jan 27, 2042
US 12,281,149 Modulators of G-Protein Coupled Receptors Oct 11, 2042
20262030203420382042
10 pending applications: term is not computable until grant.Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know

Fee deadlines

No maintenance fee falls due on this company's record before Nov 17, 2027.

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

What they patent

Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.

Showing 1 to 3 of 3

PatentTitleStatusExpiresConfidence
US 11,535,660Modulators of G-Protein Coupled Receptors
In force
 · High confidence
In forceHigh confidence
US 12,459,929GPCR Receptor Agonists, Pharmaceutical Compositions Comprising the Same, and Methods for Their Use
In force
 · Medium confidence
In forceMedium confidence
US 12,281,149Modulators of G-Protein Coupled Receptors
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 3: 1 patent in force now held by others · 10 applications pending · 8 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
1 computed term date comes from a chain with an unresolved parent. A continuity parent has not yet been fetched from USPTO's records. The term is dated from this application's own claim; no earlier date is assumed until the parent is resolved.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited